Mereo BioPharma Group plc Return On Equity in % from 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mereo BioPharma Group plc quarterly/annual Return On Equity history and growth rate from 2023 to Q3 2025.
  • Mereo BioPharma Group plc Return On Equity for the quarter ending September 30, 2025 was -75 %, a 58.9% increase year-over-year.
  • Mereo BioPharma Group plc annual Return On Equity for 2024 was -157 %, a 166% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Mereo BioPharma Group plc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -75 +107 +58.9% Jul 1, 2025 Sep 30, 2025
Q2 2025 -193 -128 -197% Apr 1, 2025 Jun 30, 2025
Q1 2025 -148 -95.2 -179% Jan 1, 2025 Mar 31, 2025
Q4 2024 -157 -98.3 -166% Oct 1, 2024 Dec 31, 2024
Q3 2024 -182 Jul 1, 2024 Sep 30, 2024
Q2 2024 -65 Apr 1, 2024 Jun 30, 2024
Q1 2024 -53.3 Jan 1, 2024 Mar 31, 2024
Q4 2023 -59.1 Oct 1, 2023 Dec 31, 2023

Mereo BioPharma Group plc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -157 -98.3 -166% Jan 1, 2024 Dec 31, 2024
2023 -59.1 Jan 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.